Zobrazeno 1 - 10
of 433
pro vyhledávání: '"M.M Samama"'
Publikováno v:
Clinical Thrombosis ISBN: 9780429261879
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d8019886b3ebc943ab0076ef54fe322
https://doi.org/10.1201/9780429261879-5
https://doi.org/10.1201/9780429261879-5
Autor:
M.M. Samama, Hau C. Kwaan
Publikováno v:
Clinical Thrombosis ISBN: 9780429261879
Clinical Thrombosis
Clinical Thrombosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15fa175d687c73457186b327d6040c13
https://doi.org/10.1201/9780429261879-2
https://doi.org/10.1201/9780429261879-2
Publikováno v:
Clinical Thrombosis ISBN: 9780429261879
Clinical Thrombosis
Clinical Thrombosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0a3ffae5f220cc4fbb87884269242d7
https://doi.org/10.1201/9780429261879-35
https://doi.org/10.1201/9780429261879-35
Publikováno v:
Clinical Thrombosis ISBN: 9780429261879
Clinical Thrombosis
Clinical Thrombosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bf1912bef9bd0839dc87d040f3a0a7e
https://doi.org/10.1201/9780429261879-7
https://doi.org/10.1201/9780429261879-7
Autor:
M.M. Samama, Hau C. Kwaan
Publikováno v:
Clinical Thrombosis ISBN: 9780429261879
Clinical Thrombosis
Clinical Thrombosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::948d55504d66ea5a3f642d1485f07a37
https://doi.org/10.1201/9780429261879-4
https://doi.org/10.1201/9780429261879-4
Publikováno v:
Journal des Maladies Vasculaires. 38:259-270
Resume Les nouveaux anticoagulants oraux a action directe sur un facteur de la coagulation, essentiellement les facteurs Xa ou IIa (thrombine), ne necessitent pas de surveillance biologique en routine. Neanmoins, ils provoquent une hypocoagulabilite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::827089b688ee7df44cf7c1ecdcd41e10
https://doi.org/10.1016/j.jmv.2013.05.005
https://doi.org/10.1016/j.jmv.2013.05.005
Publikováno v:
Archives des Maladies du Coeur et des Vaisseaux - Pratique. 2013:21-27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7df5548346aef101a81afc696131967e
https://doi.org/10.1016/s1261-694x(13)70534-0
https://doi.org/10.1016/s1261-694x(13)70534-0
Autor:
C. Carter, Ismail Elalamy, Ian A. Greer, Alexander G.G. Turpie, A. K. Kakkar, Bo Eklof, Stavros K. Kakkos, M.M. Samama, Grigorios T. Gerotziafas, Athanasios D. Giannoukas, Anthony J. Comerota, Jawed Fareed, J. Conard, Kenneth A. Myers, M. Griffin, Gordon D.O. Lowe, Joseph A. Caprini, Evi Kalodiki, Alex C. Spyropoulos, A. Markel, Jeanine M. Walenga, David Warwick, G. Geroulakos, David Bergqvist, Gary E. Raskob, Samuel Z. Goldhaber, M. R. Lassen, Paolo Prandoni, John P. Fletcher, Andrew Nicolaides, R D Hull, J. Bonnar
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis. 19:225-229
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6647fa5eb27c7ed998315a1119683926
https://doi.org/10.1177/1076029612474840w
https://doi.org/10.1177/1076029612474840w
Autor:
John P. Fletcher, David Warwick, C. Carter, M. R. Lassen, Kenneth A. Myers, G. Geroulakos, Ismail Elalamy, Paolo Prandoni, J. Bonnar, David Bergqvist, M. Griffin, Joseph A. Caprini, Evi Kalodiki, Grigorios T. Gerotziafas, Jeanine M. Walenga, J. Fareed, Alex C. Spyropoulos, R D Hull, Ian A. Greer, Alexander G.G. Turpie, J. Conard, Andrew Nicolaides, Athanasios D. Giannoukas, Anthony J. Comerota, Stavros K. Kakkos, Gary E. Raskob, Gordon D.O. Lowe, A. Markel, Samuel Z. Goldhaber, A. K. Kakkar, Bo Eklof, M.M. Samama
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis. 19:208-214
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbb21846bcbaeafd1eb93b8184607acc
https://doi.org/10.1177/1076029612474840s
https://doi.org/10.1177/1076029612474840s
Autor:
M.M. Samama, S. Meddahi
Publikováno v:
Journal des Maladies Vasculaires. 36:24-32
Resume L’inhibition de la thrombine est un objectif important pour prevenir et traiter les thromboses. Une nouvelle molecule active par voie orale le dabigatran etexilate ou Pradaxa® a obtenu l’autorisation de mise sur le marche (AMM) dans la th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4d1ed769b4c27e1122b23b431bd92ac
https://doi.org/10.1016/j.jmv.2010.11.005
https://doi.org/10.1016/j.jmv.2010.11.005